Titel

Merkliste
1 Ergebnisse

Implications for sequencing of biologic therapy and choice ..:

Chanchlani, N ; Lin, S ; Auth, MK...
https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdf. , 2022

Link: https://discovery.ucl.ac.uk/id/eprint/10155718/1/Impli..

RT Journal
T1 <Title>Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10155718&Exemplar=1&LAN=DE
				
A1 Chanchlani, N
A1 Lin, S
A1 Auth, MK
A1 Lee, CL
A1 Robbins, H
A1 Looi, S
A1 Murugesan, SV
A1 Riley, T
A1 Preston, C
A1 Stephenson, S
A1 Cardozo, W
A1 Sonwalkar, SA
A1 Allah-Ditta, M
A1 Mansfield, L
A1 Durai, D
A1 Baker, M
A1 London, I
A1 London, E
A1 Gupta, S
A1 Di Mambro, A
A1 Murphy, A
A1 Gaynor, E
A1 Jones, KDJ
A1 Claridge, A
A1 Sebastian, S
A1 Ramachandran, S
A1 Selinger, CP
A1 Borg-Bartolo, SP
A1 Knight, P
A1 Sprakes, MB
A1 Burton, J
A1 Kane, P
A1 Lupton, S
A1 Fletcher, A
A1 Gaya, DR
A1 Colbert, R
A1 Seenan, JP
A1 MacDonald, J
A1 Lynch, L
A1 McLachlan, I
A1 Shields, S
A1 Hansen, R
A1 Gervais, L
A1 Jere, M
A1 Akhtar, M
A1 Black, K
A1 Henderson, P
A1 Russell, RK
A1 Lees, CW
A1 Derikx, LAAP
A1 Lockett, M
A1 Betteridge, F
A1 De Silva, A
A1 Hussenbux, A
A1 Beckly, J
A1 Bendall, O
A1 Hart, JW
A1 Thomas, A
A1 Hamilton, B
A1 Gordon, C
A1 Chee, D
A1 McDonald, TJ
A1 Nice, R
A1 Parkinson, M
A1 Gardner-Thorpe, H
A1 Butterworth, JR
A1 Javed, A
A1 Al-Shakhshir, S
A1 Yadagiri, R
A1 Maher, S
A1 Pollok, RCG
A1 Ng, T
A1 Appiahene, P
A1 Donovan, F
A1 Lok, J
A1 Chandy, R
A1 Jagdish, R
A1 Baig, D
A1 Mahmood, Z
A1 Marsh, L
A1 Moss, A
A1 Abdulgader, A
A1 Kitchin, A
A1 Walker, GJ
A1 George, B
A1 Lim, YH
A1 Gulliver, J
A1 Bloom, S
A1 Theaker, H
A1 Carlson, S
A1 Cummings, JRF
A1 Livingstone, R
A1 Beale, A
A1 Carter, JO
A1 Bell, A
A1 Coulter, A
A1 Snook, J
A1 Stone, H
A1 Kennedy, NA
A1 Goodhand, JR
PB Wiley
YR 2022
K1 adalimumab
K1 anti-TNF
K1 antibodies
K1 drug persistence
K1 immunogenicity
K1 infliximab
K1 therapeutic drug monitoring
K1 treatment failure
JF https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdf
DO https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)